$BIXT's commitment to healthcare innovation shines through its work on oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its substantial market cap of $26.45 million and 137.77 million outstanding shares are a testament to the company's commendable progress in this vital sector.